speb/financial-data huggingface dataset:
Financial ratios for SZG.DE — quarterly report dated 2025-06-30
Total revenue: 2747294117.647059
Gross profit: 926235294.117647
Operating income: -77294117.64705883
Net income: -63882352.941176474
Capital expenditures: 311529411.7647059
Operating cash flow: 148000000
Depreciation & amortization: 93529411.76470588
Net tangible assets: 4917294117.6470585
Owner earnings: -281882352.9411765
Return on net tangible assets (%): -5.732468837476374
Buffett classification: The Gruesome
Stock price: 24.02352941176471
Shares outstanding: 54087300
Book value: 5119529411.764706
P/B ratio: 0.253806109476974
Market cap (USD): 1299367842.3529413
Debt to equity: 0
Current ratio: 1.538172678888232
Quick ratio: 0.7939384979302189
Interest coverage ratio: -2.1262135922330097
COGS to revenue (%): 66.28554299417608
Free cash flow (dilution-adjusted): -163529411.7647059
Buyback yield (%): 0
Retained earnings: 5029764705.882353
Inventory turnover: 0.6149781485895908
Receivables turnover: 1.8874878758486906
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.9484351541748469
FCF margin (%): -5.9523809523809526
Revenue growth (%): 8.500132570735977
Rule of 40 score: 2.547751618355024
Financial ratios for SZG.DE — quarterly report dated 2025-09-30
Total revenue: 2588823529.4117646
Gross profit: 942235294.117647
Operating income: 28235294.11764706
Net income: 49882352.941176474
Capital expenditures: 343882352.9411765
Operating cash flow: 274823529.41176474
Depreciation & amortization: 90705882.35294119
Net tangible assets: 5000705882.3529415
Owner earnings: -203294117.6470588
Return on net tangible assets (%): -4.0653084270455935
Capex to operating income (%): 1217.9166666666667
Buffett classification: The Gruesome
Stock price: 30.188235294117646
P/E ratio: 8.183255412735848
Shares outstanding: 54087300
Book value: 5201647058.823529
P/B ratio: 0.31390060116705115
Market cap (USD): 1632800138.8235295
Debt to equity: 0
Current ratio: 1.4728957061960526
Quick ratio: 0.7788498543075485
Effective tax rate (%): -281.98198198198196
Interest coverage ratio: 0.7667731629392972
COGS to revenue (%): 63.603726425812326
Free cash flow (dilution-adjusted): -69058823.52941176
Buyback yield (%): 0
Retained earnings: 5097294117.6470585
Inventory turnover: 0.554340937896071
Receivables turnover: 1.7626561999359178
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.345701774602443
FCF margin (%): -2.667575551011134
Revenue growth (%): -5.768242548818097
Rule of 40 score: -8.43581809982923
Financial ratios for SZG.DE — annual report dated 2025-12-31
Total revenue: 10566235294.117647
Gross profit: 3652588235.294118
Operating income: -177529411.7647059
Net income: -82117647.05882353
Capital expenditures: 1259176470.5882354
Operating cash flow: 593647058.8235295
Depreciation & amortization: 373764705.88235295
Net tangible assets: 5018000000
Owner earnings: -967529411.7647059
Return on net tangible assets (%): -19.281176001688042
Buffett classification: The Gruesome
Stock price: 47.082352941176474
Shares outstanding: 54087300
Book value: 5214941176.47059
P/B ratio: 0.4883194770681525
Market cap (USD): 2546557348.2352943
Debt to equity: 0.5010490220407425
Current ratio: 2.2687855098466403
Quick ratio: 1.1933017215600839
Interest coverage ratio: -1.1580966999232543
COGS to revenue (%): 65.43150768819659
SG&A to revenue (%): 3.4950396935855608
Free cash flow (dilution-adjusted): -665529411.7647059
Buyback yield (%): 0
Retained earnings: 5124705882.3529415
Inventory turnover: 2.3342071814426437
Receivables turnover: 8.649171802773497
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.8538311281465374
FCF margin (%): -6.298642735461459
Revenue growth (%): 1.3173175619818815
Rule of 40 score: -4.981325173479577
Financial ratios for SZG.DE — quarterly report dated 2025-12-31
Total revenue: 2489529411.764706
Gross profit: 872588235.2941177
Operating income: -68352941.1764706
Net income: -27411764.70588235
Capital expenditures: 437294117.64705884
Operating cash flow: 223529411.7647059
Depreciation & amortization: 96588235.29411764
Net tangible assets: 5018000000
Owner earnings: -368117647.0588236
Return on net tangible assets (%): -7.335943544416572
Buffett classification: The Gruesome
Stock price: 47.082352941176474
Shares outstanding: 54087300
Book value: 5214941176.47059
P/B ratio: 0.4883194770681525
Market cap (USD): 2546557348.2352943
Debt to equity: 0.5010490220407425
Current ratio: 2.2687855098466403
Quick ratio: 1.1933017215600839
Effective tax rate (%): 151.7777777777778
Interest coverage ratio: -1.6988304093567252
COGS to revenue (%): 64.94967156561599
Free cash flow (dilution-adjusted): -213764705.88235295
Buyback yield (%): 0
Retained earnings: 5124705882.3529415
Inventory turnover: 0.5459167461074039
Receivables turnover: 2.0378466872110943
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7137679824076463
FCF margin (%): -8.586550730116723
Revenue growth (%): -3.8354919336514297
Rule of 40 score: -12.422042663768153
Financial ratios for TMCI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.64
Shares outstanding: 64872976
Market cap (USD): 1209232272.64
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TMCI — annual report dated 2022-12-31
Total revenue: 141838000
Gross profit: 116306000
Operating income: -34844000
Net income: -42815000
Capital expenditures: 14838000
Operating cash flow: -30648000
Depreciation & amortization: 2133000
Net tangible assets: 60529000
Owner earnings: -55520000
Return on net tangible assets (%): -91.7246278643295
Buffett classification: The Gruesome
Stock price: 22.99
Shares outstanding: 64872976
Book value: 60529000
P/B ratio: 24.639920009251764
Market cap (USD): 1491429718.24
Debt to equity: 1.133159312065291
Current ratio: 4.410712514465201
Quick ratio: 3.7715986113407176
Interest coverage ratio: -7.922692132787631
COGS to revenue (%): 18.00081783443083
R&D to revenue (%): 9.577123196886589
SG&A to revenue (%): 96.9881131995657
Free cash flow (dilution-adjusted): -53597000
Buyback yield (%): 0
Retained earnings: -84720000
Inventory turnover: 1.3208484221417485
Receivables turnover: 4.858131250856282
Capitalized R&D asset: 13584000
ROCI (R&D-adjusted, %): -18.114257215709138
FCF margin (%): -37.7874758527334
Rule of 40 score: -37.7874758527334
Financial ratios for TMCI — annual report dated 2023-12-31
Total revenue: 187118000
Gross profit: 151937000
Operating income: -51428000
Net income: -49527000
Capital expenditures: 11458000
Operating cash flow: -34575000
Depreciation & amortization: 5352000
Net tangible assets: 116098000
Owner earnings: -55633000
Return on net tangible assets (%): -47.918999465968405
Buffett classification: The Gruesome
Stock price: 12.75
Shares outstanding: 64872976
Book value: 137938000
P/B ratio: 5.996392901158491
Market cap (USD): 827130444
Debt to equity: 0.5096710116139135
Current ratio: 4.404747629516133
Quick ratio: 3.7553349765727355
Interest coverage ratio: -9.953164311979872
COGS to revenue (%): 18.801504932716252
R&D to revenue (%): 8.251477677187658
SG&A to revenue (%): 100.43127865838667
Free cash flow (dilution-adjusted): -63385000
Buyback yield (%): 0
Retained earnings: -134247000
Inventory turnover: 1.2029748674987177
Receivables turnover: 4.916007671492
Capitalized R&D asset: 24541280
ROCI (R&D-adjusted, %): -19.73191513830317
Rosenberg metric: 2.623012367491166
FCF margin (%): -33.87434666894687
Revenue growth (%): 31.92374398962196
Rule of 40 score: -1.9506026793249092
Financial ratios for TMCI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.8
Shares outstanding: 64872976
Market cap (USD): 376263260.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TMCI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.44
Shares outstanding: 64872976
Market cap (USD): 482654941.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TMCI — annual report dated 2024-12-31
Total revenue: 209357000
Gross profit: 168264000
Operating income: -55688000
Net income: -55743000
Capital expenditures: 11593000
Operating cash flow: -37167000
Depreciation & amortization: 8419000
Net tangible assets: 92002000
Owner earnings: -58917000
Return on net tangible assets (%): -64.0388252429295
Buffett classification: The Gruesome
Stock price: 7.44
Shares outstanding: 64872976
Book value: 112892000
P/B ratio: 4.2753688608581655
Market cap (USD): 482654941.44
Debt to equity: 0.6169879176558126
Current ratio: 4.621388690050107
Quick ratio: 3.497408732999284
Interest coverage ratio: -10.595129375951293
COGS to revenue (%): 19.628194901531835
R&D to revenue (%): 9.834397703444356
SG&A to revenue (%): 97.13694789283377
Free cash flow (dilution-adjusted): -79363000
Buyback yield (%): 0
Retained earnings: -189990000
Inventory turnover: 1.0468220608839638
Receivables turnover: 5.130921745950053
Capitalized R&D asset: 35416520
ROCI (R&D-adjusted, %): -23.731664987020583
Rosenberg metric: 1.0574481865284975
FCF margin (%): -37.907975372211105
Revenue growth (%): 11.885013734648725
Rule of 40 score: -26.022961637562382
Financial ratios for TMCI — quarterly report dated 2025-03-31
Total revenue: 52570000
Gross profit: 41893000
Operating income: -15582000
Net income: -15922000
Capital expenditures: 3543000
Operating cash flow: 4198000
Depreciation & amortization: 2461000
Net tangible assets: 84689000
Owner earnings: -17004000
Return on net tangible assets (%): -20.07816835716563
Buffett classification: The Gruesome
Stock price: 8.39
Shares outstanding: 64872976
Book value: 105341000
P/B ratio: 5.166879644582831
Market cap (USD): 544284268.64
Debt to equity: 0.6584710606506489
Current ratio: 4.503827606992164
Quick ratio: 3.3603676913803495
Interest coverage ratio: -11.88558352402746
COGS to revenue (%): 20.31006277344493
R&D to revenue (%): 10.580178809206773
SG&A to revenue (%): 98.75023777820049
Free cash flow (dilution-adjusted): -8038000
Buyback yield (%): 0
Retained earnings: -205912000
Inventory turnover: 0.28141802846599895
Receivables turnover: 1.689810350369656
Capitalized R&D asset: 5562000
ROCI (R&D-adjusted, %): -6.6622528446708715
FCF margin (%): -15.290089404603386
Rule of 40 score: -15.290089404603386
Financial ratios for TMCI — quarterly report dated 2025-06-30
Total revenue: 47387000
Gross profit: 37752000
Operating income: -16974000
Net income: -17398000
Capital expenditures: 4767000
Operating cash flow: -3050000
Depreciation & amortization: 2576000
Net tangible assets: 77200000
Owner earnings: -19589000
Return on net tangible assets (%): -25.37435233160622
Buffett classification: The Gruesome
Stock price: 5.88
Shares outstanding: 64872976
Book value: 97615000
P/B ratio: 3.9077303578343496
Market cap (USD): 381453098.88
Debt to equity: 0.7180658710239205
Current ratio: 3.5227207637231506
Quick ratio: 2.5108591885441527
Interest coverage ratio: -12.849356548069645
COGS to revenue (%): 20.33258066558339
R&D to revenue (%): 11.602338194019456
SG&A to revenue (%): 103.88503175976534
Free cash flow (dilution-adjusted): -17394000
Buyback yield (%): 0
Retained earnings: -223310000
Inventory turnover: 0.2272566455173715
Receivables turnover: 1.5622259585270168
Capitalized R&D asset: 9224540
ROCI (R&D-adjusted, %): -8.725833758518228
Rosenberg metric: -0.7445163610212154
FCF margin (%): -36.70626965201427
Revenue growth (%): -9.859235305307209
Rule of 40 score: -46.56550495732148
Financial ratios for TMCI — quarterly report dated 2025-09-30
Total revenue: 50214000
Gross profit: 39706000
Operating income: -15676000
Net income: -16288000
Capital expenditures: 2809000
Operating cash flow: -9092000
Depreciation & amortization: 2778000
Net tangible assets: 69010000
Owner earnings: -16319000
Return on net tangible assets (%): -23.64729749311694
Buffett classification: The Gruesome
Stock price: 6.71
Shares outstanding: 64872976
Book value: 89187000
P/B ratio: 4.880730027470371
Market cap (USD): 435297668.96
Debt to equity: 0.7890387612544429
Current ratio: 3.3733499559988265
Quick ratio: 2.360736286300968
Interest coverage ratio: -11.715994020926756
COGS to revenue (%): 20.926434858804317
R&D to revenue (%): 9.320109929501733
SG&A to revenue (%): 100.97184052256343
Free cash flow (dilution-adjusted): -19899000
Buyback yield (%): 0
Retained earnings: -239598000
Inventory turnover: 0.25366937041328697
Receivables turnover: 1.523529233289845
Capitalized R&D asset: 10199120
ROCI (R&D-adjusted, %): -9.791692237033544
Rosenberg metric: 0.35540196435067295
FCF margin (%): -39.62839048870833
Revenue growth (%): 5.965771203072573
Rule of 40 score: -33.662619285635756
Financial ratios for TMCI — quarterly report dated 2025-12-31
Total revenue: 62519000
Gross profit: 50401000
Operating income: -5922000
Net income: -9394000
Capital expenditures: 2398000
Operating cash flow: -8026000
Depreciation & amortization: 2808000
Net tangible assets: 67392000
Owner earnings: -8984000
Return on net tangible assets (%): -13.330959164292496
Buffett classification: The Gruesome
Stock price: 2.45
Shares outstanding: 64872976
Book value: 87332000
P/B ratio: 1.819937608207759
Market cap (USD): 158938791.20000002
Debt to equity: 0.8228598909907021
Current ratio: 4.310559817202546
Quick ratio: 3.1344214134160273
Interest coverage ratio: -4.386666666666667
COGS to revenue (%): 19.38290759609079
R&D to revenue (%): 7.26499144260145
SG&A to revenue (%): 82.82442137590172
Free cash flow (dilution-adjusted): -17979000
Buyback yield (%): 0
Retained earnings: -248992000
Inventory turnover: 0.33632150092975494
Receivables turnover: 1.4830743684023246
Capitalized R&D asset: 9491940
ROCI (R&D-adjusted, %): -3.7103063615307565
Rosenberg metric: 2.28525641025641
FCF margin (%): -28.757657672067694
Revenue growth (%): 24.505118094555304
Rule of 40 score: -4.25253957751239
Financial ratios for TMCI — annual report dated 2025-12-31
Total revenue: 212690000
Gross profit: 169752000
Operating income: -54154000
Net income: -59002000
Capital expenditures: 13517000
Operating cash flow: -15970000
Depreciation & amortization: 10623000
Net tangible assets: 67392000
Owner earnings: -61896000
Return on net tangible assets (%): -91.84472934472934
Buffett classification: The Gruesome
Stock price: 2.45
Shares outstanding: 64872976
Book value: 87332000
P/B ratio: 1.819937608207759
Market cap (USD): 158938791.20000002
Debt to equity: 0.8228598909907021
Current ratio: 4.310559817202546
Quick ratio: 3.1344214134160273
Interest coverage ratio: -10.179323308270677
COGS to revenue (%): 20.188067139968968
R&D to revenue (%): 9.53594433212657
SG&A to revenue (%): 95.73745827260332
Free cash flow (dilution-adjusted): -63310000
Buyback yield (%): 0
Retained earnings: -248992000
Inventory turnover: 1.191696039521523
Receivables turnover: 5.045427588660894
Capitalized R&D asset: 39171830
ROCI (R&D-adjusted, %): -26.437779747465772
Rosenberg metric: 0.07227160134052164
FCF margin (%): -29.766326578588554
Revenue growth (%): 1.5920174629938337
Rule of 40 score: -28.17430911559472
Financial ratios for UBL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.226691283133327
Shares outstanding: 264405149
Market cap (USD): 5083636173.493869
Buyback yield (%): 0
Retained earnings: 343542133.7201635
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UBL.NS — annual report dated 2023-03-31
Total revenue: 892886723.5079173
Gross profit: 353395858.70889163
Operating income: 49412911.08404385
Net income: 37110840.438489646
Capital expenditures: 18794153.47137637
Operating cash flow: -14563946.406820951
Depreciation & amortization: 25650426.309378807
Net tangible assets: 480658952.496955
Owner earnings: 43967113.276492074
Return on net tangible assets (%): 9.147257748573946
Capex to operating income (%): 38.034904358114765
Buffett classification: The Good
Stock price: 17.0931790499391
P/E ratio: 121.78448399932718
Shares outstanding: 264405149
Book value: 483495736.906212
P/B ratio: 9.347599593126338
Market cap (USD): 4519524553.582826
Debt to equity: 0.003935004408615695
Current ratio: 1.6186672872410492
Quick ratio: 0.9917364081037647
Effective tax rate (%): 26.989528168507825
Interest coverage ratio: 91.57562076749436
COGS to revenue (%): 60.420975090715636
SG&A to revenue (%): 13.151583772133248
Free cash flow (dilution-adjusted): -33599269.183922045
Buyback yield (%): 0
Retained earnings: 320870889.1595615
Inventory turnover: 3.1021074232565957
Receivables turnover: 5.20890771111048
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.134576422770321
FCF margin (%): -3.762993479387771
Rule of 40 score: -3.762993479387771
Financial ratios for UBL.NS — annual report dated 2024-03-31
Total revenue: 944536515.1696846
Gross profit: 364770356.1578127
Operating income: 58142463.125074945
Net income: 49269696.60630771
Capital expenditures: 22866051.085262023
Operating cash flow: 8334332.653795419
Depreciation & amortization: 25410720.709917255
Net tangible assets: 499202542.27125555
Owner earnings: 51814366.23096294
Return on net tangible assets (%): 10.379427555640966
Capex to operating income (%): 39.32762710116531
Buffett classification: The Good
Stock price: 20.615403071017276
P/E ratio: 110.63227696006443
Shares outstanding: 264405149
Book value: 501686053.48363113
P/B ratio: 10.864999500858614
Market cap (USD): 5450818720.687381
Debt to equity: 0.024388319995410607
Current ratio: 1.5607165453690712
Quick ratio: 1.076914104335962
Effective tax rate (%): 25.452698044054138
Interest coverage ratio: 72.36567164179104
COGS to revenue (%): 61.38102124169522
SG&A to revenue (%): 11.884481539365884
Free cash flow (dilution-adjusted): -14630051.564935844
Buyback yield (%): 0
Retained earnings: 341443818.2036215
Inventory turnover: 3.532204801496267
Receivables turnover: 3.4040772049925665
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.477804291422835
FCF margin (%): -1.5489132849784613
Revenue growth (%): 5.78458502091384
Rule of 40 score: 4.235671735935379
Financial ratios for UBL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 503048256.09173435
Buffett classification: The Gruesome
Stock price: 25.851648351648354
Shares outstanding: 264405149
Book value: 505366698.5188724
P/B ratio: 13.525443909038913
Market cap (USD): 6835308934.313188
Debt to equity: 0.029905954482820567
Current ratio: 1.592490512283157
Quick ratio: 1.032427820163585
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UBL.NS — quarterly report dated 2024-12-31
Total revenue: 233157710.68889147
Gross profit: 100898706.1429071
Operating income: 9341415.083343046
Net income: 4490033.803473598
Capital expenditures: 0
Depreciation & amortization: 7150017.484555309
Owner earnings: 11640051.288028907
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 23.6223336053153
P/E ratio: 347.7627847595015
Shares outstanding: 264405149
Market cap (USD): 6245866636.641099
Effective tax rate (%): 37.18199608610568
Interest coverage ratio: 25.04375
COGS to revenue (%): 56.72512573365462
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UBL.NS — annual report dated 2025-03-31
Total revenue: 1042212999.7661911
Gross profit: 449682020.107552
Operating income: 71057984.56862286
Net income: 51719663.31540799
Capital expenditures: 30180032.73322422
Operating cash flow: 24963759.644610707
Depreciation & amortization: 27236380.640635956
Net tangible assets: 508545709.60953933
Owner earnings: 48776011.22281972
Return on net tangible assets (%): 9.59127376382152
Capex to operating income (%): 42.47240182287811
Buffett classification: The Good
Stock price: 23.21157661337379
P/E ratio: 118.6639660733375
Shares outstanding: 264405149
Book value: 510830021.04278696
P/B ratio: 12.014290703697615
Market cap (USD): 6137260372.984013
Debt to equity: 0.14188354189361138
Current ratio: 1.4414236282748394
Quick ratio: 1.0141368909942083
Effective tax rate (%): 26.88767331559551
Interest coverage ratio: 47.2651632970451
COGS to revenue (%): 56.85315571688003
SG&A to revenue (%): 10.981381006809803
Free cash flow (dilution-adjusted): -5925882.628010287
Buyback yield (%): 0
Retained earnings: 353805237.3158756
Inventory turnover: 3.135619853628057
Receivables turnover: 3.1164778387977474
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.690543225114757
FCF margin (%): -0.5685865201585177
Revenue growth (%): 10.34120788638426
Rule of 40 score: 9.772621366225742
Financial ratios for UBL.NS — quarterly report dated 2025-03-31
Total revenue: 271566518.58779514
Gross profit: 114712415.24433012
Operating income: 15190554.126724338
Net income: 11428571.428571427
Capital expenditures: 0
Depreciation & amortization: 6636661.211129296
Net tangible assets: 508545709.60953933
Owner earnings: 18065232.639700722
Return on net tangible assets (%): 3.5523321302958553
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 23.21157661337379
P/E ratio: 134.25257065902528
Shares outstanding: 264405149
Book value: 510830021.04278696
P/B ratio: 12.014290703697615
Market cap (USD): 6137260372.984013
Debt to equity: 0.14188354189361138
Current ratio: 1.4414236282748394
Quick ratio: 1.0141368909942083
Effective tax rate (%): 25.97864768683274
Interest coverage ratio: 22.098639455782312
COGS to revenue (%): 57.75899921652361
Buyback yield (%): 0
Retained earnings: 353805237.3158756
Inventory turnover: 0.8300575960604543
Receivables turnover: 0.8120518906674403
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9267215943132316
Revenue growth (%): 16.47331661707451
Rule of 40 score: 16.47331661707451
Financial ratios for UBL.NS — quarterly report dated 2025-06-30
Total revenue: 335164989.46875733
Gross profit: 142925345.1907325
Operating income: 29017084.01591388
Net income: 21534051.018020127
Capital expenditures: 0
Depreciation & amortization: 7363678.914111866
Owner earnings: 28897729.93213199
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 22.713550198923475
P/E ratio: 160.3512334229937
Shares outstanding: 264405149
Market cap (USD): 6005579624.665341
Effective tax rate (%): 25.758431499112472
Interest coverage ratio: 22.200537153088632
COGS to revenue (%): 57.35671991956206
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 23.419113376600347
Rule of 40 score: 23.419113376600347
Financial ratios for UBL.NS — quarterly report dated 2025-12-31
Total revenue: 230892280.27180573
Gross profit: 105076306.11562884
Operating income: 17465745.794808958
Net income: 9039768.296758384
Capital expenditures: 0
Depreciation & amortization: 7681853.62593294
Owner earnings: 16721621.922691323
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 18.065055140915675
P/E ratio: 102.7370295867559
Shares outstanding: 264405149
Market cap (USD): 4776493596.227025
Effective tax rate (%): 38.657494897573514
Interest coverage ratio: 9.29952550415184
COGS to revenue (%): 54.4911999691227
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -31.110859568663706
Rule of 40 score: -31.110859568663706
Financial ratios for VIDHIING.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.352367137017012
Shares outstanding: 49945000
Market cap (USD): 267323976.65831468
Buyback yield (%): 0
Retained earnings: 24721376.763813794
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VIDHIING.NS — annual report dated 2023-03-31
Total revenue: 48258343.48355664
Gross profit: 9811510.353227772
Operating income: 5882691.839220463
Net income: 4591961.023142509
Capital expenditures: 5216869.671132766
Operating cash flow: 11682716.199756395
Depreciation & amortization: 431315.4689403167
Net tangible assets: 29624859.926918395
Owner earnings: -193593.17904993985
Return on net tangible assets (%): -0.653482175198516
Capex to operating income (%): 88.68167522139103
Buffett classification: The Gruesome
Stock price: 3.8735688185140074
P/E ratio: 42.131323342175065
Shares outstanding: 49945000
Book value: 30539451.88794154
P/B ratio: 6.334933428097039
Market cap (USD): 193465394.6406821
Debt to equity: 0.2057521091505606
Current ratio: 2.8647614991717667
Quick ratio: 2.027783846266589
Effective tax rate (%): 24.296428679002805
Interest coverage ratio: 22.614084375146323
COGS to revenue (%): 79.668779230744
SG&A to revenue (%): 5.7159371127281355
Free cash flow (dilution-adjusted): 6465846.52862363
Buyback yield (%): 0
Retained earnings: 26942643.118148603
Inventory turnover: 5.214537999484574
Receivables turnover: 3.931821474717122
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.661487481704388
FCF margin (%): 13.398401316503492
Rule of 40 score: 13.398401316503492
Financial ratios for VIDHIING.NS — annual report dated 2024-03-31
Total revenue: 34794004.07722749
Gross profit: 9446576.328096895
Operating income: 6098752.848063317
Net income: 4370775.872406763
Capital expenditures: 2391677.6591917495
Operating cash flow: 8534572.490706319
Depreciation & amortization: 763700.683535196
Net tangible assets: 32718191.62969181
Owner earnings: 2742798.8967502094
Return on net tangible assets (%): 8.383100532552401
Capex to operating income (%): 39.21584820331317
Buffett classification: The Good
Stock price: 5.3705614203454894
P/E ratio: 61.369582419574726
Shares outstanding: 49945000
Book value: 33604233.121477395
P/B ratio: 7.982110145751861
Market cap (USD): 268232690.13915548
Debt to equity: 0.07274386325023008
Current ratio: 4.719919856047167
Quick ratio: 3.2822904835436897
Effective tax rate (%): 25.315506377747038
Interest coverage ratio: 29.809213996834888
COGS to revenue (%): 72.84998786822689
SG&A to revenue (%): 6.510316142978461
Free cash flow (dilution-adjusted): 6142894.83151457
Buyback yield (%): 0
Retained earnings: 30063065.115721308
Inventory turnover: 3.7526843921769144
Receivables turnover: 3.2845489432514126
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.82265550996292
FCF margin (%): 17.655038545951847
Revenue growth (%): -27.900542029414954
Rule of 40 score: -10.245503483463107
Financial ratios for VIDHIING.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 33645855.2317248
Buffett classification: The Gruesome
Stock price: 5.949832775919733
Shares outstanding: 49945000
Book value: 34521201.6244625
P/B ratio: 8.608170747530806
Market cap (USD): 297164397.99331105
Debt to equity: 0.10365712091041358
Current ratio: 3.5839560212819266
Quick ratio: 2.660196607271816
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VIDHIING.NS — annual report dated 2025-03-31
Total revenue: 44692892.21416881
Gross profit: 16907446.80851064
Operating income: 7118003.273322422
Net income: 5073205.517886369
Capital expenditures: 867582.4175824175
Operating cash flow: -533072.2469020342
Depreciation & amortization: 887643.2078559737
Net tangible assets: 34349193.35983165
Owner earnings: 5093266.308159924
Return on net tangible assets (%): 14.827906596828702
Capex to operating income (%): 12.188564464897498
Buffett classification: The Great
Stock price: 5.240751546271444
P/E ratio: 51.5944672565875
Shares outstanding: 49945000
Book value: 35198912.78933832
P/B ratio: 7.436290363428799
Market cap (USD): 261749335.97852725
Debt to equity: 0.21786500117074045
Current ratio: 2.916855000271663
Quick ratio: 2.050701525820104
Effective tax rate (%): 28.387979781814305
Interest coverage ratio: 24.555331505081465
COGS to revenue (%): 62.16971878326877
SG&A to revenue (%): 7.726358412044896
Free cash flow (dilution-adjusted): -1400654.6644844515
Buyback yield (%): 0
Inventory turnover: 3.1721525238235064
Receivables turnover: 2.973799191176528
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.66923011817548
FCF margin (%): -3.133953957986204
Revenue growth (%): 28.449982689460267
Rule of 40 score: 25.316028731474063
Financial ratios for VIDHIING.NS — quarterly report dated 2025-03-31
Total revenue: 12804185.1765256
Gross profit: 4892237.549684358
Operating income: 2108662.613981763
Net income: 1390647.6502221182
Capital expenditures: 0
Depreciation & amortization: 227028.29085807808
Net tangible assets: 34349193.35983165
Owner earnings: 1617675.9410801963
Return on net tangible assets (%): 4.709501979082646
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.240751546271444
P/E ratio: 47.0552939734087
Shares outstanding: 49945000
Book value: 35198924.47977554
P/B ratio: 7.436287893652039
Market cap (USD): 261749335.97852725
Debt to equity: 0.2178649288123614
Current ratio: 2.916855000271663
Quick ratio: 2.050701525820104
Effective tax rate (%): 34.87906778456729
Interest coverage ratio: 18.012282804074296
COGS to revenue (%): 61.79188693198938
Buyback yield (%): 0
Inventory turnover: 0.9032752315618078
Receivables turnover: 0.8519716141698902
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.826882709010242
Rule of 40 score: 0
Financial ratios for VIDHIING.NS — quarterly report dated 2025-06-30
Total revenue: 10285794.523753803
Gross profit: 4450046.805523052
Operating income: 2124022.9347062954
Net income: 1486414.6969342383
Capital expenditures: 0
Depreciation & amortization: 277170.60613152356
Owner earnings: 1763585.303065762
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.852445588579453
P/E ratio: 40.761739543726236
Shares outstanding: 49945000
Market cap (USD): 242355394.9216008
Effective tax rate (%): 25.946157074899727
Interest coverage ratio: 12.124707768352147
COGS to revenue (%): 56.73599355648993
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -19.668496027290033
Rule of 40 score: -19.668496027290033
Financial ratios for VIDHIING.NS — quarterly report dated 2025-09-30
Total revenue: 8454768.88387824
Gross profit: 4291138.669673055
Operating income: 1720518.6020293122
Net income: 1190450.9582863585
Capital expenditures: 0
Depreciation & amortization: 272480.2705749718
Net tangible assets: 34069233.37091319
Owner earnings: 1462931.2288613303
Return on net tangible assets (%): 4.293995150798775
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.957835400225479
P/E ratio: 48.59826489067782
Shares outstanding: 49945000
Book value: 34875152.19842164
P/B ratio: 5.668049502396373
Market cap (USD): 197674089.06426156
Debt to equity: 0.19504782076571414
Current ratio: 2.7334992081810063
Quick ratio: 1.701275755176306
Effective tax rate (%): 28.96487699210893
Interest coverage ratio: 14.243979839462385
COGS to revenue (%): 49.245937664180246
Buyback yield (%): 0
Inventory turnover: 0.3767299286453844
Receivables turnover: 0.7157986969477729
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.798125646690564
Revenue growth (%): -17.80149929737591
Rule of 40 score: -17.80149929737591
Financial ratios for VIDHIING.NS — quarterly report dated 2025-12-31
Total revenue: 10521443.68942854
Gross profit: 4511674.278712265
Operating income: 1863250.529129999
Net income: 1383212.6545616577
Capital expenditures: 0
Depreciation & amortization: 271126.211429208
Owner earnings: 1654338.8659908657
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.8760164865768076
P/E ratio: 35.51593766455347
Shares outstanding: 49945000
Market cap (USD): 193587643.42207867
Effective tax rate (%): 21.580143993937096
Interest coverage ratio: 14.920963425512936
COGS to revenue (%): 57.11924701697176
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 24.44389472893914
Rule of 40 score: 24.44389472893914
Financial ratios for WESTLIFE.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.291441382038771
Shares outstanding: 155215762
Market cap (USD): 976530868.191481
Buyback yield (%): 0
Retained earnings: 40251087.959910326
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WESTLIFE.NS — annual report dated 2023-03-31
Total revenue: 275200609.0133983
Gross profit: 142854689.4031669
Operating income: 28603410.475030452
Net income: 13590742.99634592
Capital expenditures: 32772228.98903776
Operating cash flow: 42450182.704019494
Depreciation & amortization: 18536662.606577344
Net tangible assets: 58206211.93666261
Owner earnings: -644823.386114493
Return on net tangible assets (%): -1.107825719385692
Capex to operating income (%): 114.5745505335684
Buffett classification: The Gruesome
Stock price: 8.284043848964679
P/E ratio: 94.60955731442913
Shares outstanding: 155215762
Book value: 68930572.47259438
P/B ratio: 18.653757430633313
Market cap (USD): 1285814178.4584656
Debt to equity: 2.1257474554707385
Current ratio: 0.4014793681674702
Quick ratio: 0.2849007824460497
Effective tax rate (%): 25.341077127926503
Interest coverage ratio: 2.5489970475859676
COGS to revenue (%): 48.09070738785614
SG&A to revenue (%): 5.871699395900765
Free cash flow (dilution-adjusted): 8741778.31912302
Buyback yield (%): 0.02002551139292349
Retained earnings: 50883800.24360536
Inventory turnover: 15.212174667842692
Receivables turnover: 211.2770712549093
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.800766912547884
FCF margin (%): 3.1765112549941423
Rule of 40 score: 3.1765112549941423
Financial ratios for WESTLIFE.NS — annual report dated 2024-03-31
Total revenue: 283993044.72958386
Gross profit: 145188391.8935124
Operating income: 23285405.923971698
Net income: 8299676.220170284
Capital expenditures: 25832114.16236959
Operating cash flow: 40718791.22196906
Depreciation & amortization: 21852020.62597434
Net tangible assets: 60204820.7219091
Owner earnings: 4319582.683775034
Return on net tangible assets (%): 7.174811970170185
Capex to operating income (%): 110.93692867847378
Buffett classification: The Gruesome
Stock price: 9.640235124760077
P/E ratio: 180.28612213960565
Shares outstanding: 155215762
Book value: 70543590.35855618
P/B ratio: 21.211231709973678
Market cap (USD): 1496316440.7488003
Debt to equity: 2.316185107681428
Current ratio: 0.4961843354757022
Quick ratio: 0.38739316827459014
Effective tax rate (%): 27.787863611702353
Interest coverage ratio: 1.783878880304269
COGS to revenue (%): 48.87607475325329
SG&A to revenue (%): 6.8798987255396264
Free cash flow (dilution-adjusted): 13875884.398608945
Buyback yield (%): 0
Retained earnings: 52571051.6848543
Inventory turnover: 18.303451983744207
Receivables turnover: 136.66212707022908
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.392014437069852
FCF margin (%): 4.885994448146244
Revenue growth (%): 3.1949186986564793
Rule of 40 score: 8.080913146802724
Financial ratios for WESTLIFE.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 60755136.168179646
Buffett classification: The Gruesome
Stock price: 11.268155757286193
Shares outstanding: 155215762
Book value: 71031175.34639275
P/B ratio: 24.622926111987596
Market cap (USD): 1748995382.2018635
Debt to equity: 2.4764880867300176
Current ratio: 0.6826782051490208
Quick ratio: 0.2856198326234533
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WESTLIFE.NS — quarterly report dated 2024-12-31
Total revenue: 75793927.0311225
Gross profit: 41840494.23009674
Operating income: 4222998.018417065
Net income: 817321.3661265881
Capital expenditures: 0
Depreciation & amortization: 6023032.987527683
Owner earnings: 6840354.353654271
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.22741578272526
P/E ratio: 438.08972558558435
Shares outstanding: 155215762
Market cap (USD): 1432240372.0065277
Effective tax rate (%): -8.085027669446458
Interest coverage ratio: 1.1005495289968439
COGS to revenue (%): 44.79703603045109
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WESTLIFE.NS — quarterly report dated 2025-03-31
Total revenue: 69545206.92073883
Gross profit: 38196691.606266074
Operating income: 2795744.6808510637
Net income: 177986.90671031096
Capital expenditures: 0
Depreciation & amortization: 6176852.934299743
Net tangible assets: 60642038.812251575
Owner earnings: 6354839.841010054
Return on net tangible assets (%): 10.479264822683005
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.158128136305287
P/E ratio: 1778.6000366184642
Shares outstanding: 155215762
Book value: 70550736.497545
P/B ratio: 17.948360825607086
Market cap (USD): 1266270075.170265
Debt to equity: 2.6896573436886384
Current ratio: 0.4899786036163861
Quick ratio: 0.3753873483240446
Effective tax rate (%): -13.908424360317225
Interest coverage ratio: 0.7286321466112152
COGS to revenue (%): 45.07645703060584
Buyback yield (%): 0
Retained earnings: 52669745.14846855
Inventory turnover: 3.320272897242549
Receivables turnover: 31.342976817702844
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.256615480329061
Revenue growth (%): -8.244354600887515
Rule of 40 score: -8.244354600887515
Financial ratios for WESTLIFE.NS — annual report dated 2025-03-31
Total revenue: 289236848.2581248
Gross profit: 160044084.63876548
Operating income: 13405494.505494505
Net income: 1420002.3380874444
Capital expenditures: 25420317.979892448
Operating cash flow: 40320727.14519523
Depreciation & amortization: 23860649.988309562
Net tangible assets: 60642038.812251575
Owner earnings: -139665.65349544212
Return on net tangible assets (%): -0.23031160599307773
Capex to operating income (%): 189.62611166244878
Buffett classification: The Gruesome
Stock price: 8.158128136305287
P/E ratio: 891.7380212737983
Shares outstanding: 155215762
Book value: 70550736.497545
P/B ratio: 17.948360825607086
Market cap (USD): 1266270075.170265
Debt to equity: 2.6896573436886384
Current ratio: 0.4899786036163861
Quick ratio: 0.3753873483240446
Effective tax rate (%): 6.889018351296242
Interest coverage ratio: 0.9019692669758428
COGS to revenue (%): 44.666772023481364
SG&A to revenue (%): 6.520509010836932
Free cash flow (dilution-adjusted): 14239303.249941548
Buyback yield (%): 0
Retained earnings: 52669745.14846855
Inventory turnover: 13.683430531307653
Receivables turnover: 130.35468914646998
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.025425723761923
FCF margin (%): 4.923059885244604
Revenue growth (%): 1.846454913546943
Rule of 40 score: 6.769514798791548
Financial ratios for WESTLIFE.NS — quarterly report dated 2025-06-30
Total revenue: 76439574.06974024
Gross profit: 43627860.98759654
Operating income: 3505640.0655277325
Net income: 143634.44886496608
Capital expenditures: 0
Depreciation & amortization: 6439761.291832437
Owner earnings: 6583395.7406974025
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.709571729464079
P/E ratio: 1186.945389722851
Shares outstanding: 155215762
Market cap (USD): 1351862812.6824248
Effective tax rate (%): 26.047435588731037
Interest coverage ratio: 0.8455168910337821
COGS to revenue (%): 42.92503389959718
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 9.913504401329863
Rule of 40 score: 9.913504401329863
Financial ratios for WESTLIFE.NS — quarterly report dated 2025-12-31
Total revenue: 74325342.54205191
Gross profit: 38573610.33752924
Operating income: 4572786.008688872
Net income: 113634.84460287401
Capital expenditures: 0
Depreciation & amortization: 6265289.072073076
Owner earnings: 6378923.9166759495
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.2442909658014925
P/E ratio: 773.7743405910522
Shares outstanding: 155215762
Market cap (USD): 969212380.4065946
Effective tax rate (%): 49.309282448817335
Interest coverage ratio: 1.1100838040947454
COGS to revenue (%): 48.101671626060785
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.7658860654552955
Rule of 40 score: -2.7658860654552955
Financial ratios for XSG.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.011891891891891894
Shares outstanding: 861860786
Market cap (USD): 10249155.292972974
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XSG.L — annual report dated 2022-12-31
Total revenue: 197590.36144578314
Gross profit: 101204.81927710844
Operating income: -8860240.963855423
Net income: -8353012.048192771
Capital expenditures: 75903.61445783133
Operating cash flow: -8397590.361445783
Depreciation & amortization: 174698.7951807229
Net tangible assets: 7071084.337349398
Owner earnings: -8254216.86746988
Return on net tangible assets (%): -116.73198159822797
Buffett classification: The Gruesome
Stock price: 0.0004819277108433735
Shares outstanding: 861860786
Book value: 7071084.337349398
P/B ratio: 0.05873987295961833
Market cap (USD): 415354.59566265065
Debt to equity: 0.11603339580848526
Current ratio: 5.334346504559271
Quick ratio: 5.209726443768997
Interest coverage ratio: -245.13333333333338
COGS to revenue (%): 48.78048780487805
R&D to revenue (%): 157.9268292682927
SG&A to revenue (%): 1763.4146341463413
Free cash flow (dilution-adjusted): -8378313.253012049
Buyback yield (%): 0
Retained earnings: -165991566.26506025
Inventory turnover: 0.4878048780487805
Receivables turnover: 6.833333333333333
Capitalized R&D asset: 312048.1927710844
ROCI (R&D-adjusted, %): -105.76337751595482
FCF margin (%): -4240.243902439025
Rule of 40 score: -4240.243902439025
Financial ratios for XSG.L — annual report dated 2023-12-31
Total revenue: 375949.36708860757
Gross profit: 310126.582278481
Operating income: -5979746.835443038
Net income: -5386075.949367088
Capital expenditures: 100000
Operating cash flow: -5894936.70886076
Depreciation & amortization: 191139.2405063291
Net tangible assets: 2030379.746835443
Owner earnings: -5294936.708860759
Return on net tangible assets (%): -260.785536159601
Buffett classification: The Gruesome
Stock price: 0.0003797468354430379
Shares outstanding: 861860786
Book value: 2030379.746835443
P/B ratio: 0.161195907605985
Market cap (USD): 327288.9060759493
Debt to equity: 0.5049875311720698
Current ratio: 3.286604361370717
Quick ratio: 3.0389408099688473
Interest coverage ratio: -121.12820512820514
COGS to revenue (%): 17.50841750841751
R&D to revenue (%): 28.28282828282828
SG&A to revenue (%): 679.7979797979798
Free cash flow (dilution-adjusted): -5969620.253164557
Buyback yield (%): 0
Retained earnings: -182591139.24050632
Inventory turnover: 0.32704402515723274
Receivables turnover: 29.7
Capitalized R&D asset: 315401.40308067715
ROCI (R&D-adjusted, %): -181.43122627511528
Rosenberg metric: 0.6695176188847073
FCF margin (%): -1587.878787878788
Revenue growth (%): 90.26705773386846
Rule of 40 score: -1497.6117301449194
Financial ratios for XSG.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 3897500
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 861860786
Book value: 3897500
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0.20718409236690186
Current ratio: 6.721689059500959
Quick ratio: 6.426103646833013
Retained earnings: -185696250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XSG.L — annual report dated 2024-12-31
Total revenue: 201250
Gross profit: 173750
Operating income: -5901250
Net income: -5606250
Capital expenditures: 80000
Operating cash flow: -5615000
Depreciation & amortization: 188750
Net tangible assets: 3897500
Owner earnings: -5497500
Return on net tangible assets (%): -141.05195638229634
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 861860786
Book value: 3897500
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0.20718409236690186
Current ratio: 6.721689059500959
Quick ratio: 6.426103646833013
Interest coverage ratio: -131.13888888888889
COGS to revenue (%): 13.664596273291925
R&D to revenue (%): 178.88198757763976
SG&A to revenue (%): 1113.6645962732919
Free cash flow (dilution-adjusted): -5918750
Retained earnings: -185696250
Inventory turnover: 0.14285714285714285
Receivables turnover: 53.666666666666664
Capitalized R&D asset: 534216.4099435718
ROCI (R&D-adjusted, %): -109.9302795825964
Rosenberg metric: -1.2825892857142855
FCF margin (%): -2940.993788819876
Revenue growth (%): -46.46885521885522
Rule of 40 score: -2987.4626440387315
Financial ratios for XSG.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1995890.410958904
Buffett classification: The Gruesome
Stock price: 0.00027397260273972606
Shares outstanding: 861860786
Book value: 1995890.4109589043
P/B ratio: 0.11830621633493481
Market cap (USD): 236126.24273972606
Debt to equity: 0.4131777625257378
Current ratio: 3.8134171907756813
Quick ratio: 3.4863731656184487
Buyback yield (%): 0
Retained earnings: -205793150.68493152
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2493.HK — annual report dated 2022-12-31
Total revenue: 3983933.793103448
Gross profit: 3973783.827586207
Operating income: -142442283.26293102
Net income: -137246346.59770116
Capital expenditures: 78297893.98275863
Operating cash flow: -103329187.7025862
Depreciation & amortization: 12829329.765804598
Net tangible assets: 464885583.5689655
Owner earnings: -202714910.81465518
Return on net tangible assets (%): -43.60533386696913
Buffett classification: The Gruesome
Shares outstanding: 47130200
Book value: 504398099.75287354
Debt to equity: 0.2206027744072067
Current ratio: 6.2408008131664
Quick ratio: 6.0632184952791395
Interest coverage ratio: -96.28840545499328
COGS to revenue (%): 0.25477244463278714
R&D to revenue (%): 2735.8876288927045
SG&A to revenue (%): 358.7009065131836
Free cash flow (dilution-adjusted): -203514991.81896552
Retained earnings: -387631721.26724136
Inventory turnover: 0.0008936616298841503
Receivables turnover: 369.80767137903445
Capitalized R&D asset: 108995951.78879312
ROCI (R&D-adjusted, %): -9.845179960927217
FCF margin (%): -5108.392919863993
Rule of 40 score: -5108.392919863993
Financial ratios for 2493.HK — annual report dated 2023-12-31
Total revenue: 17979681.35302391
Gross profit: 17787017.82419128
Operating income: -150514275.45288327
Net income: -148162120.48663852
Capital expenditures: 70310451.74120957
Operating cash flow: -110088365.58931082
Depreciation & amortization: 14671119.791842474
Net tangible assets: 327034023.8635724
Owner earnings: -203801452.4360056
Return on net tangible assets (%): -62.318119083849425
Buffett classification: The Gruesome
Shares outstanding: 47130200
Book value: 361919558.82559764
Debt to equity: 0.5023389816360723
Current ratio: 2.5081155088145493
Quick ratio: 2.3129880921451402
Interest coverage ratio: -80.176950040096
COGS to revenue (%): 1.0715625324484799
R&D to revenue (%): 653.7945599961766
SG&A to revenue (%): 121.65401994491853
Free cash flow (dilution-adjusted): -197024412.86497888
Retained earnings: -527615957.33895916
Inventory turnover: 0.00859913682936276
Receivables turnover: 7.300628265164644
Capitalized R&D asset: 190577466.28920868
ROCI (R&D-adjusted, %): -15.445342809437076
Rosenberg metric: 0.12673162415583714
FCF margin (%): -1095.8170447878508
Revenue growth (%): 351.304722587217
Rule of 40 score: -744.5123222006339
Financial ratios for 2493.HK — quarterly report dated 2024-12-31
Total revenue: 8039136.186301369
Gross profit: 5530427.863013699
Operating income: -45860697.234246574
Net income: -47921763.542465754
Capital expenditures: 14192802.20410959
Net tangible assets: 177712092.860274
Owner earnings: -62114565.74657534
Return on net tangible assets (%): -34.952357347686444
Buffett classification: The Gruesome
Shares outstanding: 47130200
Book value: 213120280.59315068
Debt to equity: 1.4244846477483657
Current ratio: 1.1060281607991371
Quick ratio: 0.9687252636588842
Interest coverage ratio: -17.9691932329171
COGS to revenue (%): 31.206192620078916
R&D to revenue (%): 514.3690950932769
SG&A to revenue (%): -147.01668666433986
Free cash flow (dilution-adjusted): -53675382.90547945
Retained earnings: -656886119.7205479
Inventory turnover: 0.086514528853563
Receivables turnover: 1.530519942415878
Capitalized R&D asset: 41350832.05479452
ROCI (R&D-adjusted, %): -4.399129870995737
FCF margin (%): -667.6759997789554
Rule of 40 score: -667.6759997789554